BACKGROUND: Parenteral nutrition (PN) is a common supportive care therapy in patients undergoing hematopoietic stem cell transplantation (HSCT). Inadequate oral dietary intake may necessitate prolonged courses of PN, which have been associated with metabolic, infectious, and hepatobiliary complications. The objective of this study was to identify demographic, clinical, and nutrition factors associated with the resumption of oral dietary intake following HSCT. METHODS: This was an observational cohort study of 37 children undergoing allogeneic HSCT. Repeated-measures regression analysis was performed to identify factors associated with the resumption and macronutrient composition of oral nutrient intake after HSCT. RESULTS: Mean oral dietary intake during the first 2 weeks after HSCT was <280 kcal/d. At all times, oral carbohydrate intake was high, ranging from 58% to 74% of oral energy. Age, time since transplant, degree of oral mucositis, and severity of graft-vs-host disease (GVHD) were all significantly correlated with the resumption of oral energy intake, as well as oral intake of carbohydrates. Oral protein and fat intake were also associated with elapsed time since HSCT, severity of mucositis, and GVHD. Factors not associated with oral dietary intake included gender, pre-HSCT nutrition status, diagnosis, type of donor, and infections. CONCLUSIONS: Children undergoing HSCT exhibit a marked reduction in oral dietary intake and a preference for a diet high in carbohydrates. Careful attention should be directed to the oral dietary intake and nutrient requirements of children during HSCT, especially in younger patients and those who experience severe mucositis or GVHD.
BACKGROUND: Parenteral nutrition (PN) is a common supportive care therapy in patients undergoing hematopoietic stem cell transplantation (HSCT). Inadequate oral dietary intake may necessitate prolonged courses of PN, which have been associated with metabolic, infectious, and hepatobiliary complications. The objective of this study was to identify demographic, clinical, and nutrition factors associated with the resumption of oral dietary intake following HSCT. METHODS: This was an observational cohort study of 37 children undergoing allogeneic HSCT. Repeated-measures regression analysis was performed to identify factors associated with the resumption and macronutrient composition of oral nutrient intake after HSCT. RESULTS: Mean oral dietary intake during the first 2 weeks after HSCT was <280 kcal/d. At all times, oral carbohydrate intake was high, ranging from 58% to 74% of oral energy. Age, time since transplant, degree of oral mucositis, and severity of graft-vs-host disease (GVHD) were all significantly correlated with the resumption of oral energy intake, as well as oral intake of carbohydrates. Oral protein and fat intake were also associated with elapsed time since HSCT, severity of mucositis, and GVHD. Factors not associated with oral dietary intake included gender, pre-HSCT nutrition status, diagnosis, type of donor, and infections. CONCLUSIONS:Children undergoing HSCT exhibit a marked reduction in oral dietary intake and a preference for a diet high in carbohydrates. Careful attention should be directed to the oral dietary intake and nutrient requirements of children during HSCT, especially in younger patients and those who experience severe mucositis or GVHD.
Authors: S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz Journal: J Clin Oncol Date: 2001-04-15 Impact factor: 44.544
Authors: Irene Schmid; Melanie Schmitt; Monika Streiter; Rita Meilbeck; Michael H Albert; Dietrich Reinhardt; Daniel Stachel Journal: Eur J Cancer Date: 2005-12-05 Impact factor: 9.162
Authors: Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis Journal: Cancer Date: 2004-05-01 Impact factor: 6.860
Authors: Christopher Duggan; Lori Bechard; Kate Donovan; Mark Vangel; Alice O'Leary; Colleen Holmes; Leslie Lehmann; Eva Guinan Journal: Am J Clin Nutr Date: 2003-07 Impact factor: 7.045
Authors: Tanvi S Sharma; Lori J Bechard; Henry A Feldman; Robert Venick; Kathleen Gura; Catherine M Gordon; Andrew Sonis; Eva C Guinan; Christopher Duggan Journal: Am J Clin Nutr Date: 2011-12-28 Impact factor: 7.045
Authors: Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2014-06 Impact factor: 2.839
Authors: Lori J Bechard; Henry A Feldman; Catherine Gordon; Kathleen Gura; Andrew Sonis; Kathryn Leung; Robert Venick; Eva C Guinan; Christopher Duggan Journal: Contemp Clin Trials Date: 2010-01-03 Impact factor: 2.226
Authors: Gisele Trennepohl da Costa Heinen; Daniella Schmit; Denise Johnsson Campos; Carmem Bonfim; Estela Iraci Rabito; Regina Maria Vilela Journal: Support Care Cancer Date: 2017-10-03 Impact factor: 3.603
Authors: Erika Elias Ferreira; Daiane Cristina Guerra; Kátia Baluz; Wander de Resende Furtado; Luis Fernando da Silva Bouzas Journal: Rev Bras Hematol Hemoter Date: 2014-07-18